{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042791","form_type":"8-K","ticker":"SHPH","cik":"0001757499","company_name":"Shuttle Pharmaceuticals Holdings, Inc.","filed_at":"2026-09-15T22:15:34+00:00","discovered_at":"2026-09-16T10:05:00.431974+00:00","generated_at":"2026-09-16T10:07:17.946775+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Shuttle Pharma issues 3.74M common shares on preferred conversions; adds warrants for ~17.9M shares","bullets":["As of Sept 14, 2026, issued 2,869,595 common shares on Series B-1 preferred conversion and 867,887 on Series B-2 conversion.","Issued warrants to purchase ~927,114 shares at $10.30 per share, exercisable for 3 years.","Issued pre-funded warrants to purchase ~16,932,508 shares of common stock.","All securities sold unregistered under Section 4(a)(2) exemption, following stockholder approval at Sept 9 special meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042791","json":"https://secwatch.observer/filing/0001493152-26-042791.json","markdown":"https://secwatch.observer/filing/0001493152-26-042791.md","text":"https://secwatch.observer/filing/0001493152-26-042791.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757499/000149315226042791/0001493152-26-042791-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757499/000149315226042791/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T10:07:17.946775+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}